Roy B Tishler MD
Associate Professor of Radiation Oncology, Dana-Farber Cancer Institute
Join to View Full Profile
75 Francis St# ASB1-L2Boston, MA 02115
Phone+1 617-632-3591
Fax+1 617-632-4247
Dr. Tishler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1990 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Radiation Oncology, 1988 - 1990- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1987 - 1988
Johns Hopkins University School of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 1988 - Present
CT State Medical License 2022 - 2025
MA State Medical License 1993 - 2025
ME State Medical License 2020 - 2021
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2000 Jul 14
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- Chemosensitization is not associated with improved adjuvant radiation outcomes for cutaneous squamous cell carcinoma: A dual-center retrospective cohort study.Emily E Granger, Emily Y Kim, Nina A Ran, Karina Brito, David M Wang
Journal of the American Academy of Dermatology. 2025-09-11 - 5 citationsA Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller, Bethany Sargent, Evan Carey
Clinical Cancer Research. 2025-05-01 - 2 citationsA prospectively deployed deep learning-enabled automated quality assurance tool for oncological palliative spine radiation therapy.Christopher E Kehayias, Dennis Bontempi, Sarah Quirk, Scott Friesen, Jeremy Bredfeldt
The Lancet. Digital Health. 2025-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
